Ruchitbhai M Shah (Ruchit Shah, Ruchitbhai Shah)

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 12

Top Topics

Endometrial Cancer

Radical Prostatectomy

Palliative Care

Cross Sectional

Top Venues

Future oncology (London, England)

Patient related outcome measures

Health and quality of life outcomes

Journal of medical economics

This page only lists publications with an associated author ORCID identifier.

Publications

Peter J Goebell, Rutika Raina, Stephanie Chen, Sanika Rege, Ruchitbhai M Shah, Jamie Partridge Grossman, A Reginald Waldeck
Real-world treatment of metastatic hormone-sensitive prostate cancer in the USA, Europe and Asia. Future oncology (London, England) 20 (14) (2024)
Peter J Goebell, Rutika Raina, Stephanie Chen, Sanika Rege, Ruchitbhai M Shah, Jamie Partridge Grossman, A Reginald Waldeck
Real-world treatment of metastatic hormone-sensitive prostate cancer in the USA, Europe and Asia. Future oncology (London, England) 20 (14) (2024)
Peter J Goebell, Rutika Raina, Stephanie Chen, Sanika Rege, Ruchitbhai M Shah, Jamie Partridge Grossman, A Reginald Waldeck
Real-world treatment of metastatic hormone-sensitive prostate cancer in the USA, Europe and Asia. Future oncology (London, England) (2024)
Elizabeth A Szamreta, Wei-Jhih Wang, Ruchitbhai M Shah, Shelby L Corman, Matthew Monberg
The burden of ovarian cancer in the USA from 2007 to 2018: evidence from the Medical Expenditure Panel Survey. Future oncology (London, England) (2023)
Sushmitha Inguva, Masoom Priyadarshini, Ruchitbhai M Shah, Kaustuv Bhattacharya
Financial toxicity and its impact on health outcomes and caregiver burden among adult cancer survivors in the USA. Future oncology (London, England) 18 (13) (2022)
Nehemiah Kebede, Ruchitbhai M Shah, Anuj Shah, Shelby Corman, Chizoba Nwankwo
Treatment patterns and economic burden among cervical and endometrial cancer patients newly initiating systemic therapy. Future oncology (London, England) 18 (8) (2022)
Chizoba Nwankwo, Ruchitbhai M Shah, Anuj Shah, Shelby Corman, Nehemiah Kebede
Treatment patterns and economic burden among newly diagnosed cervical and endometrial cancer patients. Future oncology (London, England) 18 (8) (2022)
Eric Armbrecht, Ruchitbhai M Shah, Gregory W Poorman, Linlin Luo, Jennifer M Stephens, Benjamin Li, Elizabeth Pappadopulos, Seema Haider, Roger S McIntyre
Economic and Humanistic Burden Associated with Depression and Anxiety Among Adults with Non-Communicable Chronic Diseases (NCCDs) in the United States. Journal of multidisciplinary healthcare 14 (2021)
Anuj Shah, Xinyi Ng, Ruchitbhai M Shah, Caitlyn T Solem, Ping Wang, Marko Obradovic
Psychometric Validation of the EQ-5D-3L in Patients with Nontuberculous Mycobacterial (NTM) Lung Disease Caused by Mycobacterium avium Complex (MAC). Patient related outcome measures 12 (2021)
Ruchitbhai M Shah, Shelby L Corman, Anuj Shah, Nehemiah Kebede, Chizoba Nwankwo
Phase-specific and lifetime economic burden of cervical cancer and endometrial cancer in a commercially insured United States population. Journal of medical economics 24 (1) (2021)
Ruchitbhai M Shah, Marc Botteman, Reginald Waldeck
Treatment characteristics for nonmetastatic castration-resistant prostate cancer in the United States, Europe and Japan. Future oncology (London, England) 15 (35) (2019)
Ruchitbhai M Shah, Benjamin F Banahan, Erin R Holmes, Amit S Patel, Marie Barnard, Rahul Khanna, John P Bentley
An evaluation of the psychometric properties of the sf-12v2 health survey among adults with hemophilia. Health and quality of life outcomes 16 (1) (2018)